
Novel degrader of the anaplastic lymphoma киназы (ALK) fusion protein, effectively inducing ALK degradation and inhibiting the growth of ALK fusion positive клетка lines, SU-DHL-1 and H3122, significantly reducing the tumor growth in H3122 xenograft model
Novel degrader of the anaplastic lymphoma kinase (ALK) fusion protein, effectively inducing ALK degradation and inhibiting the growth of ALK fusion positive cell lines, SU-DHL-1 and H3122, significantly reducing the tumor growth in H3122 xenograft model
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.